× Alert! To view the full data details, please Login or Register. Synopsis: VC SBIR-STTR Data Acquired Firms 2,869 (8.51%) Acquiring Entities 1,807 Transactions 2,951 M&A Deals Value $550.5B VC Funded Firms 1,350 Total VC Investment $56.2B Distribution of M&A transactions SBIR M&A Deals Value: non-VC & VC Funded Firms (last 10 years) SBIR M&A Num Deals: non-VC & VC Funded Firms (last 10 years) SBIR M&A Key Takeaways SBIR M&A by Price Paid: non-VC & VC Funded Firms Featured SBIR Firm Edesa Biotech Inc Stellar Biotechnologies, Inc., a biotechnology company, engaged in the aquaculture, R&D, manufacture, and distribution of keyhole limpet hemocyanin (KLH) protein. Providing KLH protein under the Stellar KLH brand, the company offers KLH, an immune-st... see more www.stellarbiotechnologies.com | (805) 488-2800 SBIR M&A & Partnering News Date Title Feb 27 2026 Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy Oct 30 2024 Opus Genetics acquired, becomes public company based in NC Apr 03 2024 Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement Nov 13 2023 Selecta Biosciences Announces Merger with Cartesian Therapeutics Aug 22 2023 Grander Closes Acquisition of PolarityTE, Inc. Assets Explanation ×
